A BROAD RANGE OF MEDICINES

THERAPEUTIC AREAS​

Intsel Chimos laboratory holds several Marketing Authorizations ('MA') across various therapeutic areas from niche products to higner volumes in order to provide a comprehensive offer to hospitals and pharmacies.

OUR MEDICINES​

We place great importance on the choice of the medicines we market in order to guarantee the quality of our services and thus benefit the patients?

NEW PRODUCTS - RUBRACA®

Since September 4, 2023, we have been the operator and distributor of RUBRACA® (available in 3 presentations RUBRACA® 200mg / RUBRACA® 250mg & RUBRACA® 300mg) indicated in oncology.

You must send your orders by email to:

adv@intselchimos.com

RCP
Avis de CT

ALPROSTADIL®

We are the owner and exploitant of Alprostadil Intsel Chimos®, which is a prostaglandin analogue.

SmPC

CUFENCE®​

We are the exploitant of Cufence® which is a drug for the digestive system and metabolism

SmPC
Avis de CT

FARYDAK®​

We are the exploitant of Farydak®, an antineoplastic drug used in cancer treatment.

SmPC
Avis de CT

Do you wish to obtain more information on one of our products ?

contact@intselchimos.com
+33 1 49 11 66 80
Contact Us
CONTACT
Close

NOUVEAUTÉ - Rubraca®

  • Depuis le 4 septembre 2023, nous sommes l’exploitant et le distributeur de RUBRACA® (disponible sous 3 présentations RUBRACA® 200mg / RUBRACA® 250mg & RUBRACA® 300mg) indiqué en oncologie. Vous devez envoyer vos commandes par email à l’adresse : adv@intselchimos.com